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Disrupting Mediator with a Short
Peptide Ligand
Jenifer K. Lum,[a] Zhiqian Wu,[b] and Anna K. Mapp*[a, b]
Although RNA polymerase II is the core enzyme that carries
out transcription, it requires a large number of accessory pro-
teins and protein complexes to regulate its activity. One of the
most important of these complexes is Mediator, a group of
20–25 protein components that is highly conserved from Sac-
charomyces cerevisiae through to humans.[1–6] The yeast Media-
tor is subdivided into three portions: a head region that con-
tacts RNA polymerase II, a middle region, and a tail (Figure 1).[7]
While the functions of most of the Mediator subunits are un-
known, a preponderance of evidence suggests that Mediator
integrates information from DNA-bound transcriptional activa-
tors and repressors to RNA polymerase II, informing it as to the
extent and level of up-regulation required.[8] It has been diffi-
cult to precisely assign the function and role of the Mediator
complex and its subunits both because most are important for
different subsets of genes and because all participate in multi-
ple protein–protein interactions. Deleterious and/or pleiotropic
effects are often observed upon either deletion or mutation of
these proteins. Molecules that inhibit particular protein–pro-
tein interactions within this complex would thus be invaluable
for parsing the role(s) of these proteins in transcriptional regu-
lation. Here, we report the first inhibitor of a protein–protein
interaction within the Mediator complex, an eight-residue pep-
tide that prevents the association of Med15 ACHTUNGTRENNUNG(Gal11) and Med14-
ACHTUNGTRENNUNG(Rgr1) at low micromolar concentrations. This peptide thus
serves as a key starting point for the development of a new
class of artificial transcriptional regulators.
Although the locations of individual proteins within each
Mediator subcomplex are not known with high precision, sev-
eral lines of evidence suggest that Med14 ACHTUNGTRENNUNG(Rgr1) (middle
module) and Med15 ACHTUNGTRENNUNG(Gal11) (tail module) reside at the interface
between the tail and middle portions.[1, 9] Genetic studies indi-
cate that Med14 ACHTUNGTRENNUNG(Rgr1) and Med15ACHTUNGTRENNUNG(Gal11) affect overlapping
but distinct sets of genes.[10] Med14 ACHTUNGTRENNUNG(Rgr1) (also known as ARC/
DRIP150, TRAP170, or CRSP150 in humans) is an essential pro-
tein and has been identified in multiple genetic screens in
S. cerevisiae as both a positive and negative regulator of tran-
scription.[9,10] Mutations in Med14ACHTUNGTRENNUNG(Rgr1) diminish Ty, GAL, and
MATa gene expression.[9] In addition, Med14ACHTUNGTRENNUNG(Rgr1) is required
for the repression of the MAL structural genes and RME1-medi-
ated repression of meiosis in haploid yeast cells under starva-
tion conditions.[11,12] However, little is known about its specific
function or interaction partners.
Med15 ACHTUNGTRENNUNG(Gal11) is commonly identified as a target of transcrip-
tional activators, interacting in vitro with more than 10 activa-
tors; studies in S. cerevisiae support the functional relevance
of these interactions.[13–22] Although a direct homologue of
Med15 ACHTUNGTRENNUNG(Gal11) has not been identified in metazoans, the amino
terminal domain with which many activators interact is pro-
posed to be a KIX domain, found in a number of metazoan co-
activators (CBP/p300 and ARC105, for example), although this
domain can be removed without a significant impact on func-
tion.[1,23] Unlike Med14 ACHTUNGTRENNUNG(Rgr1), Med15 ACHTUNGTRENNUNG(Gal11) is not an essential
protein, as deletion is not lethal but rather induces a slow-
growth phenotype.[24] Although a direct interaction has not
been demonstrated, Med14 ACHTUNGTRENNUNG(Rgr1) appears necessary for the
ACHTUNGTRENNUNGassociation of Med15 ACHTUNGTRENNUNG(Gal11) with Mediator. Mediator complex
that contains truncated versions of Med14 ACHTUNGTRENNUNG(Rgr1) does not con-
tain Med15 ACHTUNGTRENNUNG(Gal11), for example.[9] These studies thus suggest
that ligands that interact with either Med15 ACHTUNGTRENNUNG(Gal11) or Med14-
ACHTUNGTRENNUNG(Rgr1) could directly or indirectly inhibit the association of
these proteins.
In an earlier study we carried out a screen against the
middle portion of Med15 ACHTUNGTRENNUNG(Gal11) (residues 186–619) by using
two 8-residue peptide libraries of general composition Ala-
ACHTUNGTRENNUNG(Xaa)4-(Pro/Leu)-Ser-Glu and identified 37 ligands for this pro-
tein (see ref. [28] for a complete list). To identify ligands that
might target binding surfaces that Med15 ACHTUNGTRENNUNG(Gal11) uses for inter-
actions with other Mediator proteins, we carried out a BLAST
search against these short peptides to identify sequences that
had overlap with potential binding partners of Med15 ACHTUNGTRENNUNG(Gal11).
For this purpose we used the 2.1.3 BLAST protocol specifically
developed for short sequences and focused upon hits for
which there was some genetic and/or biochemical evidence of
an interaction.[25] Peptide 32 (Ala-Tyr-Phe-Glu-Val-Pro-Ser-Glu)
exhibited significant (E=75) overlap with residues 277–283
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Figure 1. A) Schematic of the organization of the Mediator complex, with
Med14 ACHTUNGTRENNUNG(Rgr1) and Med15 ACHTUNGTRENNUNG(Gal11) highlighted. B) Ligand 32 was isolated from
a binding screen against Med15 ACHTUNGTRENNUNG(186–619) and has significant similarity to a
sequence within Med14 ACHTUNGTRENNUNG(Rgr1); scr32 is the scrambled form of ligand 32.
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(Tyr-Phe-Thr-Val-Pro-Asn-Glu) in Med14 ACHTUNGTRENNUNG(Rgr1) (Figure 1B). These
residues reside in the N-terminal portion of Rgr1, which is es-
sential for viability and has the highest sequence similarity to
homologues in higher eukaryotes.[1] This result was suggestive
both of a direct interaction between Med15ACHTUNGTRENNUNG(Gal11) and Med14-
ACHTUNGTRENNUNG(Rgr1), and of a mechanism by which association of the two
proteins could be inhibited.
To investigate this hypothesis, we first identified conditions
under which the association of Med14ACHTUNGTRENNUNG(Rgr1) and Med15ACHTUNGTRENNUNG(Gal11)
could be observed. Although several fragments of Med15-
ACHTUNGTRENNUNG(Gal11) have been bacterially over-expressed and studied, con-
structs for Med14 ACHTUNGTRENNUNG(Rgr1) (123 kDa) bacterial expression have
not been reported. We thus elected to examine the interaction
of the entire protein with Med15ACHTUNGTRENNUNG(Gal11), using a protein A-
tagged variant for isolation and detection. Homologous recom-
bination in S. cerevisiae was used to tag Med14 ACHTUNGTRENNUNG(Rgr1) for isola-
tion and detection purposes by using standard protocols.[26,27]
Protein A incorporation was confirmed by PCR, and expression
of the tagged protein was verified by analysis of yeast extracts
by SDS-PAGE followed by Western blotting with the PAP anti-
body to detect the protein A-tagged Med14 ACHTUNGTRENNUNG(Rgr1). To probe
the association of Med14 ACHTUNGTRENNUNG(Rgr1) with Med15 ACHTUNGTRENNUNG(Gal11), recombi-
nant Med15 ACHTUNGTRENNUNG(Gal11) (residues 186–619) was expressed as a
ACHTUNGTRENNUNGglutathione S-transferase (GST) fusion in Rosetta2 ACHTUNGTRENNUNG(DE3) pLysS
E. coli and directly bound to glutathione agarose beads. Yeast
extracts containing protein A-tagged Med14 ACHTUNGTRENNUNG(Rgr1) in extract
buffer (200 mm Tris pH 8.0, 150 mm ammonium sulfate, 10%
glycerol, 1 mm EDTA, 2 mm dithiothreitol (DTT) and protease
inhibitors) were added to the beads, which were then rotated
at 4 8C for 2 h. The beads were thoroughly washed and heated
in SDS buffer, and equal volumes of the supernatant were ana-
lyzed by SDS-PAGE and Western blotting (Figure 2A, lane 3). A
single protein band could be seen at approximately 120 kDa,
the molecular weight of protein A-tagged Med14ACHTUNGTRENNUNG(Rgr1) ; this in-
dicated that Med14 ACHTUNGTRENNUNG(Rgr1) was retained by the solid-support-
bound Med15ACHTUNGTRENNUNG(Gal11) under these conditions. Med14 ACHTUNGTRENNUNG(Rgr1) was
not retained by the glutathione beads in control experiments
in which Med15ACHTUNGTRENNUNG(Gal11) was not present (Figure 2A, lane 2).
With conditions for observing the association of Med14-
ACHTUNGTRENNUNG(Rgr1) and Med15 ACHTUNGTRENNUNG(Gal11) in hand, we then tested whether or
not peptide 32 could inhibit the formation of this complex. For
this purpose, peptide 32 was synthesized by using standard
solid-phase synthesis techniques, and the crude material thus
obtained was purified to homogeneity by reversed-phase
HPLC. The identity of the isolated peptide was verified by elec-
trospray mass spectrometry. A portion of peptide 32 was
ACHTUNGTRENNUNGlabeled at the amino terminus with fluorescein, purified by
ACHTUNGTRENNUNGreversed-phase HPLC, and used in a fluorescence-polarization
ACHTUNGTRENNUNGexperiment to measure the affinity of peptide 32 for Med15-
ACHTUNGTRENNUNG(Gal11). Peptide 32 interacts with Med15 ACHTUNGTRENNUNG(Gal11) with a KD of
2.4 mm, similar to that of other Med15 ACHTUNGTRENNUNG(Gal11) peptide ligands
isolated from binding screens.[28] In addition to peptide 32, a
scrambled version of this sequence (scr32: Tyr-Glu-Val-Phe-Ala-
Ser-Pro-Glu) was synthesized for use as a negative control.
Yeast extracts containing protein A-tagged Med14 ACHTUNGTRENNUNG(Rgr1)
were combined with 10 mg of recombinant GST-Med15ACHTUNGTRENNUNG(Gal11)
(186–619) and glutathione agarose beads. Also included in the
mixture was peptide 32 at concentrations ranging from 1 mm
to 5 mm, and each reaction mixture was incubated with rota-
tion for 2 h at 4 8C. The beads were washed several times with
extract buffer, and the bound protein complex was separated
by SDS-PAGE and detected by Western blot analysis. As shown
in Figure 2B, at a peptide 32 concentration of 10 mm, signifi-
cant inhibition of Med15 ACHTUNGTRENNUNG(Gal11)–Med14 ACHTUNGTRENNUNG(Rgr1) association was
observed with complete inhibition at 100 mm. In contrast, the
scrambled version of peptide 32 (scr32) did not inhibit the as-
sociation of these two proteins over the same concentration
range (Figure 2C). Future in vitro cross-linking experiments in
combination with mutagenesis approaches in vivo will be
useful in distinguishing the mechanism of peptide 32-mediat-
ed inhibition. The observed inhibition could be due to direct
disruption of a Med15ACHTUNGTRENNUNG(Gal11)–Med14ACHTUNGTRENNUNG(Rgr1) interaction or an
ACHTUNGTRENNUNGindirect mechanism either through an allosteric change in
Med15 ACHTUNGTRENNUNG(Gal11) upon binding or by inhibition of other Med15-
ACHTUNGTRENNUNG(Gal11)–Mediator protein interactions.
In summary, the eight-residue peptide Ala-Tyr-Phe-Glu-Val-
Pro-Ser-Glu disrupts the association of the Mediator compo-
nents Med14ACHTUNGTRENNUNG(Rgr1) and Med15ACHTUNGTRENNUNG(Gal11), transcription proteins
important for Mediator recruitment and integration of activator
Figure 2. Med14 coprecipitates with Med15ACHTUNGTRENNUNG(Gal11), and this association is
specifically inhibited by peptide 32. A) When yeast lysates containing protein
A-tagged Med14ACHTUNGTRENNUNG(Rgr1) were combined with glutathione agarose beads, no
detectable Med14 ACHTUNGTRENNUNG(Rgr1) was precipitated (lane 2). In contrast, when GST-
tagged Med15ACHTUNGTRENNUNG(Gal11) was added to the mixture, Med14 ACHTUNGTRENNUNG(Rgr1) colocalized
with Med15 ACHTUNGTRENNUNG(Gal11) on the solid support (lane 3). B) Increasing concentrations
of peptide 32 added to a mixture of GST-tagged Med15 ACHTUNGTRENNUNG(Gal11) and yeast ly-
sates containing protein A-tagged Med14 ACHTUNGTRENNUNG(Rgr1) inhibit Med14ACHTUNGTRENNUNG(Rgr1)–Med15-
ACHTUNGTRENNUNG(Gal11) association. Lane 1: yeast lysate; lane 2: Med14 ACHTUNGTRENNUNG(Rgr1) coprecipitated
with Med15 ACHTUNGTRENNUNG(Gal11) by glutathione agarose beads; lanes 3–6: as lane 2, but
with increasing concentrations of peptide 32. C) The scrambled version of
peptide 32 (scr32) does not inhibit the association of Med15ACHTUNGTRENNUNG(Gal11) and
Med14 ACHTUNGTRENNUNG(Rgr1) at concentrations up to 100 mm under the same conditions as
used for (B).
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signals for a range of genes, at micromolar concentrations. Im-
portantly, there is some level of specificity associated with this
inhibition. The experiments were carried out with yeast lysates,
such that there was a high number of potential binding part-
ners within the assay mixture. In addition, when the sequence
of the peptide was scrambled, no discernable inhibition oc-
curred under identical conditions. As the first reported inhibi-
tor of a Mediator protein–protein interaction, peptide 32 will
be a useful mechanistic tool on a number of fronts. Perhaps
most promising, peptide 32 can be used as the starting point
for identifying nonpeptidic inhibitors through competitive
binding assays, and such molecules could have enhanced utili-
ty in cell-based experiments. Finally, other mediator compo-
nents can be submitted to similar peptide/small-molecule
screens to identify not only potential protein partners and in-
hibitors of contacts between Mediator components, but, de-
pending on the target, novel artificial transcriptional activation
domains. Future peptide/small-molecule inhibitors of Mediator
interactions will be useful for dissecting the roles of individual
subunits and mediator modules in conveying signals from
transcriptional regulators to RNA polymerase II and in preinitia-
tion complex (PIC) assembly.
Experimental Section
Isolation of protein A-tagged Med14ACHTUNGTRENNUNG(Rgr1): To C-terminally pro-
tein A-tagged Med14 ACHTUNGTRENNUNG(Rgr1) under its natural promoter, primers
containing 40 base pairs homologous to the C terminus of Med14-
ACHTUNGTRENNUNG(Rgr1) and the 3’ untranslated region of Med14 ACHTUNGTRENNUNG(Rgr1) were de-
signed to PCR and then clone the protein A tag and Kan marker
from pFA6a-KanMX6 with protein A.[26,27] The forward primer was
5’-CATAATATCCTCAAAGTGGACTCGAACTCAAGTTCATCTCGGATCCC-
ACHTUNGTRENNUNG ACHTUNGTRENNUNG GGTTAATTAA-3’. The reverse primer was 5’-CTCCTAAGGGATAGT-
ACHTUNGTRENNUNG ACHTUNGTRENNUNG CGCCGGTGACATTTTATTCGCTGAATTCGAGCTCGTTTAAAC-3’. PCR
reactions contained dNTPs (200 mm), the forward and reverse
primer (2 mm), and pFA6a-KanMX6 (100 ng; 50 mL total volume).
The amplification profile was one cycle for 3 min at 95 8C followed
by 30 cycles of 15 s at 95 8C, 1 min at 50 8C, and 2 min at 72 8C. The
final extension step was 7 min at 72 8C. The correct PCR fragment
was verified by gel electrophoresis. Several PCR reaction mixtures
were combined and transformed into S. cerevisiae (BJ2168, geno-
type: MATalpha,ura3-52,leu2,gal2,prb1-1122,1pep4-3,prc1-407) by
using the lithium acetate method. Integration of the protein A tag
at the C terminus of Med14 ACHTUNGTRENNUNG(Rgr1) was verified by Western blot and
PCR analysis of the transformed yeast colonies that survived on SC
G418 (500 mgmL1) plates. Yeast containing the integrated protein
A tag at the C terminus of Med14 ACHTUNGTRENNUNG(Rgr1) were used to inoculate an
overnight culture (50 mL), which was subsequently diluted 500-
fold to inoculate YPD media (1 L). The culture was grown to an OD
of 3 before the cells were centrifuged at 5000 rpm for 5 min. The
pellets were stored at 80 8C until needed. (http://www.fhcrc.org/
science/labs/hahn/methods/methods_index.html) In order to lyse,
the cells the pellet was washed with sterilized ddH2O (50 mL) then
extract buffer (200 mm Tris-HCl pH 8.0, 150 mm ammonium sulfate,
10% glycerol, 1 mm EDTA, 2 mm DTT, Roche protease inhibitor
tablet; 25 mL) both prechilled to 4 8C. The cells were resuspended
in extract buffer and lysed by using glass beads at 4 8C with a
1 min vortex, 1 min cooling cycle, repeated 5 times. The glass
bead–cell lysate mixture was centrifuged for 3 min at 14000 rpm
and 4 8C, and the supernatant was centrifuged again for 30 min at
14000 rpm and 4 8C. The supernatant was concentrated in a spin
filter, and aliquots (1 mL) were used in pull-down experiments.
GST-Med15ACHTUNGTRENNUNG(Gal11) ACHTUNGTRENNUNG(186–619) was over-expressed in Rosetta2 ACHTUNGTRENNUNG(DE3)
pLysS E. coli cells and isolated as previously described.[28]
Competitive inhibition experiments: For the peptide competition
experiments, GST–Med15 (186–619) (50 mL, 20 mm) was added with
yeast extracts (1 mL) and a range of concentrations of peptide 32
or scrambled peptide 32 (scr32) to glutathione beads (50 mL) and
mixed end on end at 4 8C for 2 h. The beads were washed with
ACHTUNGTRENNUNGextract buffer (3M ), and the bound protein was eluted by boiling
in NUPAGE LDS 4M loading buffer. The supernatant (15 mL) was
loaded and separated by SDS-PAGE and detected by Western blot
by using chemiluminescence.
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